drugset / Trial / NCT01262729

Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation

NCT01262729

Phase 2 Terminated 5 enrolled RWTH Aachen University
RandomizedParallel-groupOpen-labelTreatment

Summary

In this clinical trial will be checked, whether 2 hour ventilation with xenon has neuroprotective effects in patients with out of hospital cardiac arrest and successful cardiopulmonary resuscitation

Timeline

Start
2011-09
Primary completion
2014-11
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenon Other / unclassified 65 % Inhaled
Subject Xenon Other / unclassified 70 % Inhaled

Indications